Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
University of Washington School of Medicine - Barnes-Jewish Hospital
mi
from
St Louis, MO
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
University of Washington School of Medicine - Barnes-Jewish Hospital
mi
from
St Louis, MO
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
Mt. Sinai Medical Center
mi
from
New York, NY
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Mt. Sinai Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
Duke Univ Med Ctr
mi
from
Durham, NC
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
Cleveland Clinic
mi
from
Cleveland, OH
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
Oregon Health and Science University
mi
from
Portland, OR
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
Univ of Pennsylvania
mi
from
Philadelphia, PA
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
Virginia Commonwealth University
mi
from
Richmond, VA
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Randomized Trial of Aggressive Fluid Hydration to Prevent Post ERCP Pancreatitis
Feasibility Study of a Randomized Trial of Aggressive Fluid Hydration to Prevent Post ERCP Pancreatitis
Status: Enrolling
Updated:  12/24/2012
Los Angeles County Hospital
mi
from
Los Angeles, CA
Randomized Trial of Aggressive Fluid Hydration to Prevent Post ERCP Pancreatitis
Feasibility Study of a Randomized Trial of Aggressive Fluid Hydration to Prevent Post ERCP Pancreatitis
Status: Enrolling
Updated: 12/24/2012
Los Angeles County Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of SSP-004184 (SPD602) in Healthy Adults and Subjects With Impaired Liver Function
A Phase 1, Open-label, Single-dose Study of the Pharmacokinetics, Safety, and Tolerability of SSP-004184 (SPD602) in Subjects With Hepatic Impairment Compared to Matched Healthy Subjects
Status: Enrolling
Updated:  1/9/2013
Clinical Pharmacology of Miami
mi
from
Miami, FL
Study of SSP-004184 (SPD602) in Healthy Adults and Subjects With Impaired Liver Function
A Phase 1, Open-label, Single-dose Study of the Pharmacokinetics, Safety, and Tolerability of SSP-004184 (SPD602) in Subjects With Hepatic Impairment Compared to Matched Healthy Subjects
Status: Enrolling
Updated: 1/9/2013
Clinical Pharmacology of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-II)
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Birmingham, AL
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-II)
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-II)
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Los Angeles, CA
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-II)
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-II)
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
San Diego, CA
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-II)
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-II)
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Kansas City, MO
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-II)
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-II)
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Monticello, NY
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-II)
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Monticello, NY
Click here to add this to my saved trials
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-II)
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Cincinnati, OH
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-II)
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-II)
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
San Antonio, TX
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-II)
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-II)
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Newport News, VA
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-II)
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Newport News, VA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-II)
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Norfolk, VA
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-II)
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-II)
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Madison, WI
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-II)
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Vitamin D and Adipose Tissue Inflammation
Vitamin D and Adipose Tissue Inflammation
Status: Enrolling
Updated:  1/15/2013
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Vitamin D and Adipose Tissue Inflammation
Vitamin D and Adipose Tissue Inflammation
Status: Enrolling
Updated: 1/15/2013
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Intraperitoneal Versus Extraperitoneal Colostomy
Prospective Randomized Trial of Intraperitoneal Versus Extraperitoneal Techniques for Construction of Terminal Iliac Fossa Colostomies
Status: Enrolling
Updated:  1/16/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Intraperitoneal Versus Extraperitoneal Colostomy
Prospective Randomized Trial of Intraperitoneal Versus Extraperitoneal Techniques for Construction of Terminal Iliac Fossa Colostomies
Status: Enrolling
Updated: 1/16/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors
A Phase I Dose Escalation Study of a 2 Day Oral Lapatinib Chemosensitization Pulse Given Prior To Weekly Intravenous Abraxane™ in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  1/17/2013
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors
A Phase I Dose Escalation Study of a 2 Day Oral Lapatinib Chemosensitization Pulse Given Prior To Weekly Intravenous Abraxane™ in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 1/17/2013
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Improving Clinician Communication Skills (ICCS)
Improving Patient Outcomes in End-of-Life Care Provided by Physicians and Nurses
Status: Enrolling
Updated:  1/21/2013
Medical University of South Carolina
mi
from
Charleston, SC
Improving Clinician Communication Skills (ICCS)
Improving Patient Outcomes in End-of-Life Care Provided by Physicians and Nurses
Status: Enrolling
Updated: 1/21/2013
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Improving Clinician Communication Skills (ICCS)
Improving Patient Outcomes in End-of-Life Care Provided by Physicians and Nurses
Status: Enrolling
Updated:  1/21/2013
University of Washington; Harborview Medical Center
mi
from
Seattle, WA
Improving Clinician Communication Skills (ICCS)
Improving Patient Outcomes in End-of-Life Care Provided by Physicians and Nurses
Status: Enrolling
Updated: 1/21/2013
University of Washington; Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Improving Clinician Communication Skills (ICCS)
Improving Patient Outcomes in End-of-Life Care Provided by Physicians and Nurses
Status: Enrolling
Updated:  1/21/2013
University of Washington; UW Medical Center
mi
from
Seattle, WA
Improving Clinician Communication Skills (ICCS)
Improving Patient Outcomes in End-of-Life Care Provided by Physicians and Nurses
Status: Enrolling
Updated: 1/21/2013
University of Washington; UW Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Improving Clinician Communication Skills (ICCS)
Improving Patient Outcomes in End-of-Life Care Provided by Physicians and Nurses
Status: Enrolling
Updated:  1/21/2013
Veteran's Affairs Puget Sound HCS
mi
from
Seattle, WA
Improving Clinician Communication Skills (ICCS)
Improving Patient Outcomes in End-of-Life Care Provided by Physicians and Nurses
Status: Enrolling
Updated: 1/21/2013
Veteran's Affairs Puget Sound HCS
mi
from
Seattle, WA
Click here to add this to my saved trials
Inflammatory Cytokine Quantification in Infants
Inflammatory Cytokine Quantification in Infants With Documented Sepsis, Congenital Diaphragmatic Hernia and/or ECMO Therapy
Status: Enrolling
Updated:  1/22/2013
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Inflammatory Cytokine Quantification in Infants
Inflammatory Cytokine Quantification in Infants With Documented Sepsis, Congenital Diaphragmatic Hernia and/or ECMO Therapy
Status: Enrolling
Updated: 1/22/2013
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Inflammatory Cytokine Quantification in Infants
Inflammatory Cytokine Quantification in Infants With Documented Sepsis, Congenital Diaphragmatic Hernia and/or ECMO Therapy
Status: Enrolling
Updated:  1/22/2013
University of Utah
mi
from
Salt Lake City, UT
Inflammatory Cytokine Quantification in Infants
Inflammatory Cytokine Quantification in Infants With Documented Sepsis, Congenital Diaphragmatic Hernia and/or ECMO Therapy
Status: Enrolling
Updated: 1/22/2013
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease
Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease
Status: Enrolling
Updated:  1/23/2013
University of Medicine and Dentistry of New Jersey
mi
from
Newark, NJ
Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease
Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease
Status: Enrolling
Updated: 1/23/2013
University of Medicine and Dentistry of New Jersey
mi
from
Newark, NJ
Click here to add this to my saved trials
Development of an Imaging Biomarker for Hepatic Fibrosis Using Gadoxetate Disodium
Development of an Imaging Biomarker for Hepatic Fibrosis Using Gadoxetate Disodium
Status: Enrolling
Updated:  1/31/2013
Weill-Cornell Medical College
mi
from
New York, NY
Development of an Imaging Biomarker for Hepatic Fibrosis Using Gadoxetate Disodium
Development of an Imaging Biomarker for Hepatic Fibrosis Using Gadoxetate Disodium
Status: Enrolling
Updated: 1/31/2013
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated:  2/1/2013
Alabama Orthopedic Clinic
mi
from
Mobile, AL
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated: 2/1/2013
Alabama Orthopedic Clinic
mi
from
Mobile, AL
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated:  2/1/2013
Clinical Research Advantage, Inc./ Mesa Family Medical Center
mi
from
Mesa, AZ
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated: 2/1/2013
Clinical Research Advantage, Inc./ Mesa Family Medical Center
mi
from
Mesa, AZ
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated:  2/1/2013
Clinical Research Advantage, Inc. / East Valley Family Physicians, PLC
mi
from
Tempe, AZ
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated: 2/1/2013
Clinical Research Advantage, Inc. / East Valley Family Physicians, PLC
mi
from
Tempe, AZ
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated:  2/1/2013
Clinical Research Advantage, Inc.
mi
from
Tempe, AZ
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated: 2/1/2013
Clinical Research Advantage, Inc.
mi
from
Tempe, AZ
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated:  2/1/2013
Premiere Pharamaceutical Research, LLC
mi
from
Tempe, AZ
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated: 2/1/2013
Premiere Pharamaceutical Research, LLC
mi
from
Tempe, AZ
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated:  2/1/2013
Advanced Clinical Therapeutics
mi
from
Tucson, AZ
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated: 2/1/2013
Advanced Clinical Therapeutics
mi
from
Tucson, AZ
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated:  2/1/2013
Wilson and Charani
mi
from
Tucson, AZ
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated: 2/1/2013
Wilson and Charani
mi
from
Tucson, AZ
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated:  2/1/2013
Advanced Clinical Research Institute
mi
from
Anaheim, CA
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated: 2/1/2013
Advanced Clinical Research Institute
mi
from
Anaheim, CA
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated:  2/1/2013
Northern California Research Corporation
mi
from
Sacramento, CA
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated: 2/1/2013
Northern California Research Corporation
mi
from
Sacramento, CA
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated:  2/1/2013
Clinicos, LLC
mi
from
Colorado Springs, CO
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated: 2/1/2013
Clinicos, LLC
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated:  2/1/2013
Clinical Physiology Associates/Clinical Study Center
mi
from
Fort Meyers, FL
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated: 2/1/2013
Clinical Physiology Associates/Clinical Study Center
mi
from
Fort Meyers, FL
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated:  2/1/2013
Century Clinical Research
mi
from
Holly Hill, FL
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated: 2/1/2013
Century Clinical Research
mi
from
Holly Hill, FL
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated:  2/1/2013
Florida Institute of Medical Research
mi
from
Jacksonville, FL
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated: 2/1/2013
Florida Institute of Medical Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated:  2/1/2013
Accord Clinical Research
mi
from
Port Orange, FL
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated: 2/1/2013
Accord Clinical Research
mi
from
Port Orange, FL
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated:  2/1/2013
Clinical Research of West Florida, Inc.
mi
from
Tampa, FL
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated: 2/1/2013
Clinical Research of West Florida, Inc.
mi
from
Tampa, FL
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated:  2/1/2013
Stedman Clinical Trials
mi
from
Tampa, FL
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated: 2/1/2013
Stedman Clinical Trials
mi
from
Tampa, FL
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated:  2/1/2013
Best Clinical Research
mi
from
Decatur, GA
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated: 2/1/2013
Best Clinical Research
mi
from
Decatur, GA
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated:  2/1/2013
Millenium Pain Center
mi
from
Bloomington, IL
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated: 2/1/2013
Millenium Pain Center
mi
from
Bloomington, IL
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated:  2/1/2013
Columbia Medical Practice/ RxTrials, Inc.
mi
from
Columbia, MD
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated: 2/1/2013
Columbia Medical Practice/ RxTrials, Inc.
mi
from
Columbia, MD
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated:  2/1/2013
MedVadis Research Corporation
mi
from
Wellesley Hills, MA
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction
Status: Enrolling
Updated: 2/1/2013
MedVadis Research Corporation
mi
from
Wellesley Hills, MA
Click here to add this to my saved trials